Press release
Investigation announced for Investors in shares of Integra LifeSciences Holdings Corporation (NASDAQ: IART)
An investigation on behalf of investors in Integra LifeSciences Holdings Corporation (NASDAQ: IART) shares.
Investors who purchased shares of Integra LifeSciences Holdings Corporation (NASDAQ: IART) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Integra LifeSciences Holdings Corporation directors breached their fiduciary duties and caused damage to the company and its shareholders.
Princeton, NJ based Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care and otolaryngology. Integra LifeSciences Holdings Corporation reported that its annual Total Revenue rose from over $1.54 billion in 2021 to over $1.55 billion in 2022, and that its Net Income increased from $136.15 million in 2021 to $180.55 million in 2022.
On May 23, 2023, Integra LifeSciences Holdings Corporation announced that it had conducted an internal investigation, leading to a global recall of all products produced at its Boston, Massachusetts facility. The affected products were distributed between March 1, 2018, and May 22, 2023. Integra LifeSciences Holdings Corporation ceased manufacturing operations at the facility. The reason behind these actions was the company "identified deviations with endotoxin testing that may have resulted in the release of products with higher levels of endotoxins than permitted by the product specifications."
Shares of Integra LifeSciences Holdings Corporation (NASDAQ: IART) declined from $50.87 per share on May 22, 2023, to as low as $37.44 per share on May 31, 2023.
Those who purchased shares of Integra LifeSciences Holdings Corporation (NASDAQ: IART) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in shares of Integra LifeSciences Holdings Corporation (NASDAQ: IART) here
News-ID: 3094575 • Views: …
More Releases from Shareholders Foundation
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Integra
Oculoplastic Surgery Market to Eyewitness Huge Growth by 2030 | Integra Lifescie …
Advance Market Analytics published a new research publication on "Oculoplastic Surgery Market Insights, to 2028" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Oculoplastic Surgery market was mainly driven by the increasing R&D spending across the world.
Get Free Exclusive PDF Sample Copy of…
Dermal Regeneration Template Market | Integra LifeScience
The Dermal Regeneration Template market report presents the global Dermal Regeneration Template sales and revenue by companies, regions, type and application and forecast to 2027. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.
Dermal Regeneration Template Market competition landscape by sales volume, price (USD/Unit), revenue (Million USD), cost profit analysis…
Oculoplastic Surgery Market: What are the Future Growth Opportunities? Top Playe …
This detailed market study covers oculoplastic surgery market growth potentials which can assist the stake holders to understand key trends and prospects in oculoplastic surgery market identifying the growth opportunities and competitive scenarios. The report also focuses on data from different primary and secondary sources, and is analyzed using various tools. It helps to gain insights into the market's growth potential, which can help investors identify scope and opportunities. The…
Global Oculoplastic Surgery Market 2020 | B. Braun Melsungen AG, Blink Medical L …
The Global Oculoplastic Surgery Market research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry validated market data. It also contains projections using a suitable set of assumptions and methodologies. The study provides company profiling, product picture and specifications, sales, market share and contact information of key manufacturers of Global Oculoplastic Surgery Market.The Key manufactures involved in this market…
Global Hydrocephalus Shunts Market 2017- Johnson & Johnson,Integra LifeSciences
The report entitled Global Hydrocephalus Shunts Market 2017 presents key insights into the global Hydrocephalus Shunts market along with the latest up-to-date industry details and forthcoming Hydrocephalus Shunts industry trends, which will assist the readers to focus on product specification and end users driving the overall market revenue and profitability.
Report Keynotes:
The main motive of the report on "Global Hydrocephalus Shunts Market 2017" is to study comprehensive details of the market…
Integra, Inc Completes Interface with Medicine-On-Time
Carson City, NV—February 27, 2009 – Integra, Inc. and Medicine-On-Time have released an interface between Integra’s industry leading set of work flow and document management solutions, DocuTrack and DeliveryTrack, and Medicine-On-Time’s personal prescription system.
DocuTrack allows users to streamline pharmacy work flow through the automation of all paper, fax and electronic processing. DeliveryTrack is a complete delivery management solution providing electronic signature capture, real-time proof of delivery, bar code scanning of…
